Ferric Maltol interactions
Full monograph for Ferric MaltolCheck it against another medicine
Medicines
98 documented
| Medicine | Severity | Mechanism | Effect | Sources |
|---|---|---|---|---|
| Alendronic acid | Moderate | Absorption | Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to interfere with… | 6 sources — open the full entry |
| Alendronic Acid + Vitamin D3 | Moderate | Absorption | Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to interfere with… | 6 sources — open the full entry |
| Aluminium Hydroxide + Magnesium Hydroxide | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The…2 documented mechanisms | 12 sources — open the full entry |
| Aluminium Hydroxide + Magnesium Hydroxide + Simethicone | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The…2 documented mechanisms | 12 sources — open the full entry |
| Aluminium Oxide + Magnesium Trisilicate | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The… | 12 sources — open the full entry |
| Baloxavir Marboxil | Moderate | Absorption | Coadministration with polyvalent cation-containing products may decrease the plasma concentrations and therapeutic efficacy of baloxavir. The proposed… | 1 sources — open the full entry |
| Beclomethasone Dipropionate + Chloramphenicol + Clotrimazole + Lidocaine | Moderate | Metabolism | Chloramphenicol can cause bone marrow depression and inhibit red blood cell maturation, which may interfere with the therapeutic effects of iron or vitamin B12… | 3 sources — open the full entry |
| Beta carotene + Vitamin C + Vitamin E | Moderate | Antagonism | Limited data suggest that vitamin E may diminish the therapeutic response to iron therapy in patients with iron deficiency anemia. | 2 sources — open the full entry |
| Calcium acetate + Magnesium carbonate | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The… | 12 sources — open the full entry |
| Calcium Carbonate | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The… | 12 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin C | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The… | 12 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin C + Vitamin D3 | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The… | 12 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin D3 | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The… | 12 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin D3 + Multiminerals | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The… | 12 sources — open the full entry |
| Carbidopa + LevodopaExtended releaseProlonged release | Moderate | Absorption | The oral bioavailability and pharmacologic effects of levodopa and carbidopa may be decreased during concurrent administration with iron-containing products… | 4 sources — open the full entry |
| Cefdinir | Moderate | Absorption | The oral bioavailability of cefdinir may be significantly decreased by concomitant administration of iron preparations. The proposed mechanism is chelation of… | 2 sources — open the full entry |
| Chloramphenicol (Oral) | Moderate | Metabolism | Chloramphenicol can cause bone marrow depression and inhibit red blood cell maturation, which may interfere with the therapeutic effects of iron or vitamin B12… | 3 sources — open the full entry |
| Chloramphenicol + Lidocaine Hydrochloride | Moderate | Metabolism | Chloramphenicol can cause bone marrow depression and inhibit red blood cell maturation, which may interfere with the therapeutic effects of iron or vitamin B12… | 3 sources — open the full entry |
| CiprofloxacinbaseOphthalmic | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Ciprofloxacin + Dexamethasone | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Ciprofloxacin + Hydrocortisone Acetate | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Clobetasol Propionate + Ofloxacin + Ornidazole + Terbinafine | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Deferiprone | Moderate | Antagonism | Deferiprone has the potential to bind polyvalent cations such as aluminum, iron and zinc, which may reduce its effectiveness. However, concurrent use with… | 1 sources — open the full entry |
| Delafloxacin | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Dexamethasone + Chloramphenicol | Moderate | Metabolism | Chloramphenicol can cause bone marrow depression and inhibit red blood cell maturation, which may interfere with the therapeutic effects of iron or vitamin B12… | 3 sources — open the full entry |
| Dexamethasone + Levofloxacin | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Dexlansoprazole | Moderate | Absorption | Inhibitors of the proton pump (PPIs or potassium-competitive acid blockers [PCABs]) may impair the gastrointestinal absorption of nonheme iron, a process that… | 12 sources — open the full entry |
| Doxycycline Hydrochloride | Moderate | Absorption | The bioavailability of oral tetracyclines and iron salts may be significantly decreased during concurrent administration. Therapeutic failure may result. The… | 11 sources — open the full entry |
| Eltrombopag Olamine | Moderate | Absorption | Products containing aluminum, calcium, iron, magnesium, zinc and other polyvalent cations such as antacids or mineral supplements can significantly reduce the… | 2 sources — open the full entry |
| EsomeprazolebaseMUPS preparation | Moderate | Absorption | Inhibitors of the proton pump (PPIs or potassium-competitive acid blockers [PCABs]) may impair the gastrointestinal absorption of nonheme iron, a process that… | 12 sources — open the full entry |
| Esomeprazole + Amoxicillin + Clarithromycin | Moderate | Absorption | Inhibitors of the proton pump (PPIs or potassium-competitive acid blockers [PCABs]) may impair the gastrointestinal absorption of nonheme iron, a process that… | 12 sources — open the full entry |
| Ferric Carboxymaltose | Moderate | Absorption | Parenteral iron therapy may reduce the absorption of concomitantly administered oral iron preparations. | 5 sources — open the full entry |
| Ferric Derisomaltose | Moderate | Absorption | Parenteral iron therapy may reduce the absorption of concomitantly administered oral iron preparations. | 5 sources — open the full entry |
| Ferric Pyrophosphate Citrate | Moderate | Absorption | Parenteral iron therapy may reduce the absorption of concomitantly administered oral iron preparations. | 5 sources — open the full entry |
| Gatifloxacin | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Gatifloxacin + Dexamethasone | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Gemifloxacin | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Ibandronic Acid | Moderate | Absorption | Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to interfere with… | 6 sources — open the full entry |
| Ibandronic Acid + Algae Calcium + Vitamin D3 | Moderate | Absorption | Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to interfere with… | 6 sources — open the full entry |
| Ibandronic Acid + Coral Calcium + Vitamin D3 | Moderate | Absorption | Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to interfere with… | 6 sources — open the full entry |
| Iron Sucrose | Moderate | Absorption | Parenteral iron therapy may reduce the absorption of concomitantly administered oral iron preparations. | 5 sources — open the full entry |
| Lansoprazole | Moderate | Absorption | Inhibitors of the proton pump (PPIs or potassium-competitive acid blockers [PCABs]) may impair the gastrointestinal absorption of nonheme iron, a process that… | 12 sources — open the full entry |
| Lansoprazole + Amoxicillin + Clarithromycin | Moderate | Absorption | Inhibitors of the proton pump (PPIs or potassium-competitive acid blockers [PCABs]) may impair the gastrointestinal absorption of nonheme iron, a process that… | 12 sources — open the full entry |
| Lanthanum Carbonate | Moderate | Absorption | Theoretically, lanthanum carbonate may chelate with certain drugs in the gastrointestinal tract, resulting in reduced oral bioavailability of those drugs… | 6 sources — open the full entry |
| Levodopa + Benserazide | Moderate | Absorption | The oral bioavailability and pharmacologic effects of levodopa and carbidopa may be decreased during concurrent administration with iron-containing products… | 4 sources — open the full entry |
| Levodopa + Carbidopa | Moderate | Absorption | The oral bioavailability and pharmacologic effects of levodopa and carbidopa may be decreased during concurrent administration with iron-containing products… | 4 sources — open the full entry |
| Levodopa + Carbidopa + Entacapone | Moderate | Absorption | The oral bioavailability of entacapone and iron salts may be decreased during concurrent administration. The proposed mechanism is chelation of iron by…2 documented mechanisms | 5 sources — open the full entry |
| Levofloxacin (Eye/Ear) | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Levofloxacin Hemihydrate | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Levothyroxine Sodium | Moderate | Absorption | Concurrent administration of iron-containing products may decrease the oral bioavailability and pharmacologic effects of levothyroxine. The exact mechanism of… | 1 sources — open the full entry |
Food & lifestyle
food
ModerateAbsorption
Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.
What to do: Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect. Some studies suggest administration of iron with ascorbic acid may enhance bioavailability. In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased. Consult the product labeling for specific separation times and monitor clinical responses as appropriate.
2 sources
- "Product Information. Feosol (ferrous sulfate)." SmithKline Beecham
- "Product Information. Accrufer (ferric maltol)." Shield Therapeutics (2021):
Conditions
Conditions in which Ferric Maltol needs care, as documented in this source.
Inflammatory Bowel Diseases
ModerateIron can be irritating and damaging to gastrointestinal mucosa. Iron therapy should be avoided during an active flare of inflammatory bowel disease.
1 source
- "Product Information. Accrufer (ferric maltol)." Shield Therapeutics (2021):